Work

The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, is protective in two murine models of colitis

Year: 2003

Type: article

Source: European Journal of Pharmacology

DOI: 10.1016/s0014-2999(03)01570-x

Authors: Jon Mabley, Francisco Soriano, Pál Pacher, György Haskó, Anita Marton, Rebecca Wallace, Andrew Salzman, Csaba Szabó

Institutions: Inotek Pharmaceuticals (United States), Rutgers New Jersey Medical School

Language: English

Topic: Adenosine and Purinergic Signaling

Subfield: Physiology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

Award: ADENOSINE 3 RECEPTOR AGONIST FOR TREATMENT OF COLITIS

OpenAlex ID: W2113136182

FWCI: 2.481

Cites: 39

Cited by: 112

Related to: 10